Foresight Analytics recently completed a ratings assessment of both the Trilogy Monthly Income Trust and the Trilogy Enhanced Income Fund, assigning both a ‘Very Strong’ investment rating.
This rating reaffirms the previous Foresight Analytics assessment from December 2024.
A ‘Very Strong’ rating indicates a very strong conviction that the fund can deliver a risk-adjusted return in line with its positive absolute return objective and that it is suitable for inclusion on most approved product lists.
In its assessment of the Trilogy Monthly Income Trust, Foresight Analytics highlighted Trilogy Funds’ experience and commitment to ‘developing very strong loan management systems.’
The report also noted that historically the Trilogy Monthly Income Trust ‘has a strong track record of managing non-performing loans using conservative leverage ratios, careful stress-testing of project costs, and thorough credit analysis to minimise defaults. This has enabled it to meet its stated objective of generating competitive income through a portfolio of loans secured by registered first mortgages on Australian properties.’
In its assessment of the Trilogy Enhanced Income Fund, Foresight Analytics noted that the team at Trilogy Funds ‘leverage their many years of experience with multiple checks and balances to enable the Fund to achieve its objectives. The Fund has consistently outperformed its benchmark.’
Download the full reports below.
The information contained in the Foresight Analytics report and encapsulated in the investment rating is of a general nature only. The report and rating reflect the opinion of Foresight Analytics and Ratings Pty Limited (AFSL 494552). It does not take into account an individual’s objectives, financial situation or needs. Professional advice should be sought before making an investment decision. A fee has been paid by the fund manager for the production of the report and investment rating.
This article is issued by Trilogy Funds Management Limited ABN 59 080 383 679 AFSL 261425 (Trilogy Funds) as responsible entity for the Trilogy Monthly Income Trust ARSN 121 846 722 and Trilogy Enhanced Income Fund ARSN 614 682 469. Application for investment can only be made on the application form accompanying the Product Disclosure Statement (PDS) dated 3 May 2024 for the Trilogy Monthly Income Trust ARSN 121 846 722 and PDS dated 10 April 2024 for the Trilogy Enhanced Income Fund ARSN 614 682 469. The PDS and Target Market Determination (TMD) for both products are available at www.trilogyfunds.com.au. The PDS contains full details of the terms and conditions of investment and should be read in full, particularly the risk section prior to lodging any application or making a further investment. All investments, including those with Trilogy Funds, involve risk which can lead to no or lower than expected returns, or a loss of part or all of your capital. Trilogy Funds is licensed to provide only general financial product advice about its products and therefore recommends you seek personal advice on the suitability of this investment to your objectives, financial situation and needs from a licensed financial adviser. Investments with Trilogy Funds are not bank deposits and are not government guaranteed. Past performance is no indicator of future performance.
